Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

S&P 500 Healthcare Sector SPDR (XLV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family State Street Global Advisors
  • Assets Under Management 19,618,096,000
  • Market Capitalization, $K 19,618,096
  • Shares Outstanding, K 211,265
  • 36-Month Beta 1.00
  • Price/Book 3.99
  • Price/Earnings ttm 16.63
  • Annual Dividend & Yield 1.36 (1.47%)
  • Most Recent Dividend 0.380 on 12/21/18
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
87.49 +5.88%
on 01/28/19
92.99 -0.39%
on 02/19/19
+2.55 (+2.83%)
since 01/18/19
3-Month
80.61 +14.91%
on 12/26/18
95.92 -3.43%
on 12/04/18
+1.76 (+1.94%)
since 11/19/18
52-Week
78.74 +17.64%
on 04/02/18
96.06 -3.57%
on 10/01/18
+7.22 (+8.45%)
since 02/16/18

Most Recent Stories

More News
Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?

Sector ETF report for PTH

XLV : 92.63 (-0.24%)
VHT : 174.10 (-0.29%)
PTH : 81.76 (-0.70%)
EXAS : 85.57 (-3.37%)
AMED : 132.70 (-2.58%)
CI : 198.28 (+0.21%)
5 ETFs to Tap for February

These five ETFs could be worth investing in.

PXJ : 7.31 (+0.55%)
XLV : 92.63 (-0.24%)
HIPS : 16.98 (+0.47%)
SDY : 98.86 (+0.37%)
MJ : 35.63 (-0.17%)
5 ETFs to Tap for February

These five ETFs could be worth investing in.

PXJ : 7.31 (+0.55%)
XLV : 92.63 (-0.24%)
HIPS : 16.98 (+0.47%)
SDY : 98.86 (+0.37%)
MJ : 35.63 (-0.17%)
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

Sector ETF report for PSCH

XLV : 92.63 (-0.24%)
VHT : 174.10 (-0.29%)
LHCG : 110.47 (-2.26%)
AMED : 132.70 (-2.58%)
NEOG : 62.64 (-0.56%)
PSCH : 122.58 (-0.33%)
Best ETF Ideas for 2019

How should investors position their portfolio for 2019? Here are some ideas.

XLV : 92.63 (-0.24%)
XWEB : 89.77 (+0.64%)
SDY : 98.86 (+0.37%)
SPYV : 30.31 (+0.33%)
XSW : 91.43 (+0.18%)
QUS : 80.99 (+0.21%)
KBE : 45.29 (+0.82%)
Healthcare ETFs in Focus Ahead of Q4 Earnings

With lower negative earnings revisions, the healthcare sector is expected to witness earnings growth of 7.7% in the fourth quarter, suggesting continued outperformance for healthcare ETFs.

XLV : 92.63 (-0.24%)
VHT : 174.10 (-0.29%)
MRK : 79.24 (-0.71%)
IYH : 195.00 (-0.27%)
FHLC : 44.82 (-0.24%)
ABBV : 80.52 (-0.41%)
GILD : 66.76 (-1.23%)
AMGN : 186.97 (-0.73%)
PFE : 42.60 (+0.47%)
Healthcare ETFs in Focus Ahead of Q4 Earnings

With lower negative earnings revisions, the healthcare sector is expected to witness earnings growth of 7.7% in the fourth quarter, suggesting continued outperformance for healthcare ETFs.

XLV : 92.63 (-0.24%)
VHT : 174.10 (-0.29%)
MRK : 79.24 (-0.71%)
IYH : 195.00 (-0.27%)
FHLC : 44.82 (-0.24%)
ABBV : 80.52 (-0.41%)
GILD : 66.76 (-1.23%)
AMGN : 186.97 (-0.73%)
PFE : 42.60 (+0.47%)
JNJ Beats, Offers Bleak Outlook: Health Care ETFs in Focus

Johnson & Johnson expects its sales growth to slow down this year due to pricing pressures and generic-drug competition for its pharmaceutical division. This has put healthcare ETFs in focus.

XLV : 92.63 (-0.24%)
VHT : 174.10 (-0.29%)
JNJ : 135.69 (-0.51%)
IHE : 151.85 (-0.26%)
IYH : 195.00 (-0.27%)
IEIH : 25.86 (-0.61%)
JNJ Beats, Offers Bleak Outlook: Health Care ETFs in Focus

Johnson & Johnson expects its sales growth to slow down this year due to pricing pressures and generic-drug competition for its pharmaceutical division. This has put healthcare ETFs in focus.

XLV : 92.63 (-0.24%)
VHT : 174.10 (-0.29%)
JNJ : 135.69 (-0.51%)
IHE : 151.85 (-0.26%)
IYH : 195.00 (-0.27%)
IEIH : 25.86 (-0.61%)
UnitedHealth Pops on Solid Q4: Healthcare ETFs to Buy

ETFs having the largest allocation to UnitedHealth has been in focus post its solid result.

VHT : 174.10 (-0.29%)
XLV : 92.63 (-0.24%)
IEHS : 29.02 (-0.07%)
IHF : 185.15 (-0.19%)
IYH : 195.00 (-0.27%)
UNH : 270.41 (-0.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade XLV with:

Fund Summary

The Health Care Select Sector SPDR Fund seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the Health Care Select Sector Index.

See More

Key Turning Points

2nd Resistance Point 93.14
1st Resistance Point 92.88
Last Price 92.63
1st Support Level 92.48
2nd Support Level 92.34

See More

52-Week High 96.06
Last Price 92.63
Fibonacci 61.8% 89.44
Fibonacci 50% 87.40
Fibonacci 38.2% 85.36
52-Week Low 78.74

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar